Feature Channels: Kidney Disease

Filters close
Released: 1-Oct-2024 2:05 PM EDT
American Society of Nephrology Launches the Glomerular Diseases Collaborative (Gd-C) to Address Gaps in Knowledge and Barriers in the Care of People with Glomerular Diseases
American Society of Nephrology (ASN)

Chronic kidney disease is a progressive condition that affects more than 10% of the general population worldwide, amounting to 800 million individuals.1 Glomerular diseases (GD), excluding diabetic nephropathy, account for approximately 25% of the cases of kidney diseases worldwide.2 Given the magnitude of long-term morbidity from GD— particularly the frequent manifestation in younger patients—diagnosing it efficiently and optimizing management to control diseases and prevent progressive kidney diseases is paramount.

Not for public release

This news release is embargoed until 30-Sep-2024 5:00 PM EDT Released to reporters: 24-Sep-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 30-Sep-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 30-Sep-2024 8:35 AM EDT
Kidney Week 2024 to Explore a World Without Kidney Diseases
American Society of Nephrology (ASN)

Largest Global Gathering of Kidney Professionals Expands Program to Include More Breaking Research and Focused Discussions on Key Public Health and Policy Issues

Newswise: Nickolas to lead Division of Bone and Mineral Diseases
Released: 26-Sep-2024 11:05 AM EDT
Nickolas to lead Division of Bone and Mineral Diseases
Washington University in St. Louis

Thomas Nickolas, MD, has been named the next director of the Division of Bone and Mineral Diseases in the Department of Medicine at Washington University School of Medicine in St. Louis. He comes to WashU Medicine from Columbia University and will begin his new role in January.

Newswise: The Cancer Research Institute and the Kidney Cancer Association Announce a Collaboration to Co-Fund Kidney Cancer Immunotherapy Research
Released: 24-Sep-2024 11:05 AM EDT
The Cancer Research Institute and the Kidney Cancer Association Announce a Collaboration to Co-Fund Kidney Cancer Immunotherapy Research
Cancer Research Institute

The Cancer Research Institute and the Kidney Cancer Association are collaborating on a new kidney cancer immunotherapy research grant.

Released: 20-Sep-2024 2:05 PM EDT
Cleveland Clinic Study Shows Bariatric Surgery Outperforms GLP-1 Diabetes Drugs for Kidney Protection
Cleveland Clinic

Friday, September 20, 2024, CLEVELAND: A Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery was associated with a significant decrease in the progression of chronic kidney disease compared to those who received GLP-1 diabetes medications. The paper was published in Annals of Surgery.

Newswise: Dedication, Teamwork Key to Performing 10 Kidney Transplants in Two Days
Released: 19-Sep-2024 3:05 PM EDT
Dedication, Teamwork Key to Performing 10 Kidney Transplants in Two Days
Vanderbilt University Medical Center

It was truly a Labor Day weekend to remember at Vanderbilt University Medical Center, where transplant teams performed 10 kidney transplants in two days — and that was before even getting to Labor Day.

Newswise: Pushing Kidney-Stone Fragments Reduces Stones’ Recurrence
Released: 19-Sep-2024 2:05 PM EDT
Pushing Kidney-Stone Fragments Reduces Stones’ Recurrence
University of Washington School of Medicine and UW Medicine

UW Medicine researchers found that patients who underwent the stone-moving ultrasound procedure had a 70% lower risk of such a recurrence. The Journal of Urology published the findings in August.

Newswise:/images/icons/audio_thumb_100x75.png
AUDIO
Released: 18-Sep-2024 2:05 PM EDT
ASN Kidney Health Guidance on the Management of Obesity in Persons Living with Kidney Diseases
American Society of Nephrology (ASN)

ASN Kidney Translation Series podcast episode, led by Matt Sparks, related to the ASN New Initiative Kidney Health Guidance on the Management of Obesity in Persons Living with Kidney Diseases.

12-Sep-2024 4:00 PM EDT
American Society of Nephrology Releases Kidney Health Guidance on the Management of Obesity in Persons with Kidney Diseases
American Society of Nephrology (ASN)

To promote high-quality, person-directed care across the spectrum of kidney health and diseases the American Society of Nephrology (ASN) is releasing its inaugural Kidney Health Guidance (KHG) on the Management of Obesity in Persons Living with Kidney Diseases in the Journal of the American Society of Nephrology (JASN) on September 18, 2024.

Newswise: sabygeorgenewweb.jpg
Released: 15-Sep-2024 11:05 AM EDT
Roswell Park-Designed Treatment Regimen Doubles Progression-Free Survival in Metastatic Kidney Cancer
Roswell Park Comprehensive Cancer Center

During the European Society for Medical Oncology (ESMO) Congress, Saby George, MD, FACP, of Roswell Park Comprehensive Cancer Center presented findings on a novel two-agent treatment that more than doubled progression-free survival compared with single-agent treatment.

Newswise: Repeat Immune Checkpoint Inhibitor Therapy Not Recommended for Advanced Kidney Cancer
Released: 13-Sep-2024 10:05 AM EDT
Repeat Immune Checkpoint Inhibitor Therapy Not Recommended for Advanced Kidney Cancer
Dana-Farber Cancer Institute

In an international multicenter randomized phase 3 clinical trial led by Dana-Farber Cancer Institute, researchers tested the addition of the immune checkpoint inhibitor (ICI) nivolumab to treatment with tivozanib for patients with advanced clear cell renal cell carcinoma.

Newswise: Comprehensive cancer research from Dana-Farber to lead ESMO Congress 2024
9-Sep-2024 8:05 AM EDT
Comprehensive cancer research from Dana-Farber to lead ESMO Congress 2024
Dana-Farber Cancer Institute

Novel treatments, including targeted therapies and antibody drug conjugates, as well as research into improving quality of life for patients with breast cancer, headline studies led by Dana-Farber Cancer Institute and presented at the European Society of Medical Oncology (ESMO) Congress 2024 in Barcelona, Spain.

Newswise: Urate Transporter Structures Reveal the Mechanism Behind Important Drug Target for Gout
Released: 9-Sep-2024 11:05 AM EDT
Urate Transporter Structures Reveal the Mechanism Behind Important Drug Target for Gout
St. Jude Children's Research Hospital

Ten structures of URAT1 obtained by scientists at St. Jude Children’s Research Hospital provide a deep understanding of the mechanism of urate transport to guide gout therapeutic design.

Newswise: One of the First of Its Kind, Uah Study Characterizes Urinary Microbes in Children
Released: 6-Sep-2024 3:05 PM EDT
One of the First of Its Kind, Uah Study Characterizes Urinary Microbes in Children
University of Alabama Huntsville

Until recently, it was believed that human urine is sterile, but advanced culturing techniques and DNA sequencing have revealed that bacteria and other microbes – such as viruses and fungi – inhabit the human bladder and urinary tract, known collectively as the “urobiome.” Now in study that is one of the first of its kind, Dr.

Newswise: Widespread disparities exist in treating advanced cancers
Released: 4-Sep-2024 11:05 AM EDT
Widespread disparities exist in treating advanced cancers
UT Southwestern Medical Center

A study led by researchers at UT Southwestern Medical Center reveals significant disparities across the country in the use of immunotherapy for patients with advanced kidney and bladder cancers.

Released: 28-Aug-2024 7:00 AM EDT
Presión arterial alta daña los riñones
Mayo Clinic

La hipertensión, también conocida como presión arterial alta, es un problema común que afecta las arterias del cuerpo. Si tiene presión arterial alta, el corazón tiene que trabajar más para bombear la sangre.

Released: 21-Aug-2024 1:05 PM EDT
Two Women from the Same Church Receive Organ Transplants Three Days Apart
Loyola Medicine

Two women who attend the same church and have been praying for one another to find a match, recently received transplants at Loyola University Medical Center just three days apart.

Not for public release

This news release is embargoed until 19-Aug-2024 5:00 PM EDT Released to reporters: 13-Aug-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 19-Aug-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.



close
2.33972